Discuss your research with your peers
Would you like to react to this message? Create an account in a few clicks or log in to continue.

The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3

Go down

The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3 Empty The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3

Post  Jon Moulton Fri Nov 06, 2015 10:38 am

Cullere X, Plovie E, Bennett PM, MacRae CA, Mayadas TN. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3. Proc Natl Acad Sci U S A. 2015 Nov 4. pii: 201510495. [Epub ahead of print]
Jon Moulton
Jon Moulton

Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA

http://www.gene-tools.com

Back to top Go down

Back to top

- Similar topics

 
Permissions in this forum:
You cannot reply to topics in this forum